Aktiespot

LENSAR, Inc. aktie

LNSR

After-hours
$5.60-0.02 (-0.36%)
Post-Market:$5.600.00 (0.00%)
Laddar diagram...

LENSAR, Inc.

Öppning5.63
Högsta5.73
Lägsta5.50
Volym46.52k
P/EN/A
Börsvärde67.78M
52 veckors högsta13.67
52 veckors lägsta5.06
Genomsnittlig volym119.36k
UtdelningN/A
Beta0.87
EPS-0.55

Om LENSAR, Inc. aktie

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Företagsinformation

Börs: NasdaqCM (NCM)
Sektor: Sundhed
Industri: Medicinsk udstyr
Adress:
2800 Discovery Drive
32826 Orlando, United States
Telefon: + 888 536 7271

Analytikernas aktierekommendationer

Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.

Lägsta kursmål
7.00
25.0%
Genomsnittligt kursmål
8.50
51.8%
Median kursmål
8.50
51.8%
Högsta kursmål
10.00
78.6%

Andra tittar också på: